University Hospital of South Manchester
Manchester, M23 9LT, United Kingdom
NCT Number: NCT01252225
People cough in order to clear their airways. Most coughs are caused by viruses and settle down by themselves, but some people develop persistent coughing which can be anywhere from 8 weeks to several years. This is called chronic cough. People with chronic cough find the symptom distressing and it can have a major impact on their quality of life. Patients with chronic cough often report a sensation at the back of their throat which makes them feel an urge to cough. There is some evidence that Lidocaine (an anaesthetic used during medical procedures) can suppress a person's cough when given to patients via a nebuliser (a machine that turns liquid into a fine mist).
It is currently unknown whether using a local anaesthetic, such as Lidocaine, in the form of a throat spray would successfully suppress a person's cough. A throat spray would be an easier treatment option in chronic cough patients. Thus, the investigators research aims to compare cough rates, severity and urge to cough scores between Lidocaine throat spray and nebulised Lidocaine.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Manchester, M23 9LT, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
o Asthma.
600 mg Nebulised Lidocaine ( 6 mls of 10 % Lidocaine) one-off dose
Other names: Lidocaine, Lignocaine
6 mls of 0.9% saline nebulised followed by 1 ml of 0.9% saline as throat spray
Time frame: over 24 hours following treatment
patients will wear a cough recorder device for a 24 hour period. The recordings will then be analysed to reveal how many times the patient coughed.
Time frame: over 2 hours
to document any change in heart rate after treatment
Time frame: over 24 hours following treatment
Duration of mouth numbness will be subjectively assessed by asking patients about the presence of mouth numbness and its duration after treatment.
Time frame: 15 minutes after treatment
ECG will be recorded before treatment and 15 minutes after treatment to rule out any arrhythmias
Manchester University NHS Foundation Trust
Other Gov
Effect of Lidocaine and Its Delivery in Patients With Chronic Cough
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07003347
Chronic Cough, Cough
Riyadh, Saudi Arabia
View Trial DetailsNCT04765722
Asthma, Bronchial Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT04866563
Chronic Cough, Cough
Birmingham, England, United Kingdom
View Trial DetailsNCT05689307
Chronic Cough, Cough
Bellingham, Washington, United States
View Trial Details